A review of evidence for the use of pneumococcal conjugate vaccine in South Africa showed that children who are HIV positive are at significantly increased risk of pneumococcal disease, and so will benefit the most from vaccination, despite decreased vaccine efficacy in this group compared to healthy children.
Full Citation:
Zar, H.J. and Madhi, S.A.. 2008. Pneumococcal conjugate vaccine – a health priority. South African Medical Journal. 98(6).
Title of Article: Pneumococcal conjugate vaccine – a health priority
Author(s): Zar, H.J. and Madhi, S.A.
Publication Year: 2008
Publication Name: South African Medical Journal
Publication Volume: 98(6)
Publication Source URL: http://www.scielo.org.za/scielo.php?script=sci_arttext&pid=S0256-95742008000600020
DOI (Digital Object Identifier): PMID: 18683380
Topics: Health
Disease Vaccines: Pneumococcal disease/PCV/PPSV | Pneumonia
Countries: South Africa
WHO Regions: Africa